Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Hypophosphatemia With Intravenous Ferric Carboxymaltose Versus Iron Dextran in Women With Iron Deficiency Secondary to Heavy Uterine Bleeding

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2013 by Luitpold Pharmaceuticals.
Recruitment status was  Active, not recruiting
Information provided by:
Luitpold Pharmaceuticals Identifier:
First received: October 4, 2010
Last updated: July 1, 2013
Last verified: July 2013
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)